EGFR and non-small cell lung carcinoma: For example, the potential efficacy of epidermal growth factor receptor (EGFR) inhibitors was reported for non-small cell lung cancer, but it was concluded that EGFR inhibitors were not appropriate as single agents for advanced AML [8,9].